Pricing structure
Thrive Rx memberships start at $1,248/year (Detect) with telehealth consults, clinical reviews, and a 6 to 12 month care plan. Hemexa is $1,199/year all-in, without the consult-led care plan.
Thrive Rx is a clinician-led telehealth longevity program: AHPRA-registered practitioners, tiered pathology from Detect ($1,248/year) to Optimise ($2,848/year), and ongoing consults over 6 to 12 months. It is one of Australia's most structured proactive care pathways.
If you want comprehensive pathology and a living blood record without a $1,248+ telehealth program, Hemexa is AU$1,199/year all-in: GP-reviewed requests, Laverty collection nationwide, 77+ signature markers on baseline, Included six-month retest on fast-moving markers, a health-system dashboard, self-serve pathology PDF imports, and supplement insights tied to your blood results.
Your annual baseline includes 77+ signature markers (77 for men, 81 for women), including 13 calculated insights from your lab results. Measured draws depend on sex (64–68). Fast-moving markers are tested again on your included six-month retest.
Thrive Rx pairs tiered pathology with AHPRA telehealth clinicians, structured reviews at 12 weeks and ongoing, and optional medications or peptides where clinically appropriate (billed separately at pharmacy retail with no markup). Prescriptions are never guaranteed; it is not a script service.
Hemexa is for Australians who want platform-led blood intelligence: upload your own pathology PDFs, see health-system scores and trends, and get supplement insights linked to your markers, without stepping into a consult-heavy care plan or separate medication billing.
Thrive Rx is built for Australians who want a regulated, AHPRA-led longevity pathway: structured consults, tiered pathology, and optional prescribing over 6 to 12 months. Hemexa is built for Australians who want comprehensive pathology and a living blood record at a lower annual price, without stepping into a consult-heavy telehealth program.
Thrive Rx memberships start at $1,248/year (Detect) with telehealth consults, clinical reviews, and a 6 to 12 month care plan. Hemexa is $1,199/year all-in, without the consult-led care plan.
Thrive Rx pairs pathology with AHPRA clinician oversight, protocols, and medications or peptides where clinically appropriate (billed separately at pharmacy retail). Hemexa focuses on blood intelligence: health-system scores, trends, and a plan after every panel without prescribing upsells.
Thrive Rx clinicians can review recent pathology at intake, but specialised longevity panels included in your membership are still required. Hemexa lets you upload pathology PDFs yourself after your first baseline, so older results sit in your timeline on your terms.
Hemexa includes 77+ signature markers on baseline and an included six-month retest at AU$1,199/year all-in. Thrive Rx Detect starts at $1,248/year with 30+ core markers; Optimise reaches 60+ comprehensive markers at $2,848/year.
After your first Hemexa panel, upload PDFs from other Australian pathology providers yourself. Thrive Rx can review recent results at intake, but specialised longevity panels are still required and past results are not a self-serve timeline import.
Log your stack and get platform insights connected to your marker results after each panel. Thrive Rx addresses supplements through clinician protocols and optional prescribing; Hemexa ties them directly to your dashboard signals.
Hemexa is built for comprehensive blood tracking at one annual price, with no prescribing upsell.
A side-by-side for Australians comparing Thrive Rx with other options. Look past tiered pathology: how you bring in past results, how supplements connect to your blood, and whether you want a clinician-led care plan or an all-in blood intelligence membership.
| Feature | Thrive Rx | Vively | Everlab | Function Health | Hemexa |
|---|---|---|---|---|---|
| Available in Australia | Yes | Yes | Yes (select states for full program) | No (US only) | Yes |
| Annual price (from) | From $1,248/yr (Detect) | From $99 baseline + app | $299 consult, plans $499 to $2,700 | ~US$365/yr | $1,199/yr all-in |
| Signature biomarkers (year one) | 30+ (Detect); up to 60+ (Optimise) | 70+ baseline | 90+ (Full Advanced Bloods) | 100+ (US panel) | 90+ across the year |
| Six-month retest included | Yes (2 panels/year) | Varies by membership | On programs only | Yes (US members) | Yes, included |
| Australian pathology network | Partner laboratories | 4,000+ collection centres | 1,850+ partner labs | Quest (US only) | Laverty nationwide |
| Clinical review of results | AHPRA telehealth clinicians | Practitioner review in app | Longevity doctor review | US clinician workflow | GP-reviewed test requests |
| Health-system dashboard | Yes (platform) | Yes (app) | Yes (app dashboard) | Results-focused | Systems, scores, and trends |
| Personalised health plan | Clinician protocols | Yes | Yes (doctor-led) | Summary-style | Yes, after every panel |
| Bring in past pathology from other labs | Partial (reviewed at intake) | No | Concierge (team requests records) | No | Yes, upload past PDFs |
| Blood-linked supplement insights | Clinician protocols (+ prescribing) | Limited | Doctor-led in intervention plans | Listed at signup | Yes, tied to your markers |
| Prescribing / peptides | Yes, where clinically appropriate (meds extra) | Not the focus | Varies by program | Limited | Blood-first; not a prescribing service |
| Primary model | Clinician-led telehealth care | CGM + metabolic baseline | Premium longevity clinic | US subscription panel | AU biomarker membership |
Competitor pricing and inclusions change. Confirm current details on each provider website before you decide.
Thrive Rx excels at clinician-led longevity care. Hemexa is AU$1,199/year all-in for Australians who want comprehensive pathology, imports, and a living record without telehealth consult upsells.
No provider is right for everyone. Choose based on what you actually want from your next blood test or membership, then join Hemexa if the wedge fits.
Hemexa is a preventative health membership and health intelligence platform. It does not provide medical advice, diagnosis, treatment, or emergency care. Always discuss results and health decisions with your GP or qualified clinician. Read our health disclaimer.
Start your membership in the member app. Or browse all 77+ markers before you decide.